Effective therapy with Bismuth-212 labeled macroaggregated albumin in orthotopic mouse breast tumor models.

Kauffman, Nathan; Singh, Satyendra Kumar; Morrison, James; Zinn, Kurt R

Kauffman, Nathan; Singh, Satyendra Kumar; Morrison, James; Zinn, Kurt R.

Afiliação

Kauffman N; Comparative Medicine and Integrative Biology, Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, United States.
Singh SK; Department of Biomedical Engineering, Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, United States.
Morrison J; Advanced Radiology Services, Grand Rapids, MI, United States.
Zinn KR; Departments of Radiology, Biomedical Engineering, Small Animal Clinical Sciences, Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, United States.

Front Chem ; 11: 1204872, 2023.

Article em En | MEDLINE | ID: mdl-37234203

Palavras-chave

Bismuth-212 (Bi-212); alpha-particle; cancer therapy; interventional radiology (IR); macroaggregated albumin (MAA); radiopharmaceutical

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Chem Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google